Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Sustained release is achieved by incorporating exendin-4 into 0.06 mm diameter biodegradable microspheres containing 50:50 poly (D,L-lactide-co-glycolide) (PLG) polymer and sucrose
Bioglutide (NA-931) presents a novel quadruple-agonist mechanism that is scientifically ambitious, targeting GLP-1, GIP, glucagon, and IGF-1 receptors in a single oral molecule
Brazil, India and China represent the countries with the highest frequencies of research involving GPXs in biotic stress in plants ( Figure 3B )
Noom Health developed its Metabolic Suite offering to address this integration opportunity
US$ 20.15
US$ 21.85
US$ 22.49
US$ 21.27
US$ 20.59
US$ 29.58
